Inhibitory effect of somatostatin on human T lymphocytes proliferation
- 1 June 1998
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 19 (11-12) , 721-727
- https://doi.org/10.1016/s0192-0561(97)00033-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Somatostatin and the immune and haematopoetic system; a reviewEuropean Journal of Clinical Investigation, 1994
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.The Journal of Experimental Medicine, 1991
- Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activationJournal of Neuroimmunology, 1991
- CD3+ WT31− peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the α/β heterodimerEuropean Journal of Immunology, 1986
- Anti‐CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation I. Pairs of anti‐T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12‐O‐tetradecanoylphorbol 13‐acetateEuropean Journal of Immunology, 1986
- An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor proteinCell, 1984
- Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.The Journal of Experimental Medicine, 1983
- Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagonDiabetes, 1981